depression glp 1 Ozempic and mental health: GLP-1 drugs tied to lower risk Do GLP-1s Work for Depression—or

A.LiR.HuangJ.HannoufaA

To summarize the open-label extension of VESPER-1, berobenatide 2.4 mg weekly demonstrated 16% weight loss at 32 weeks, a favorable benefit-risk profile for monthly dosing, and safety and tolerability consistent with the class with no discontinuations related to gastrointestinal adverse events, and the gastrointestinal tolerability was excellent, said John B

Some studies have shown that more than 90% of patients with ME/CFS have Orthostatic Intolerance

If you want to get the most out of carnitine, it is useful to combine it with physical activity and a well-structured diet

It helps to curtail overeating by acting on the appetite centers within the brain